SWOG clinical trial number
SWOG-9306

Conservative Treatment of Adenocarcinoma of the Distal Rectum: Local Resection Plus Adjuvant 5-FU/Radiation Therapy, A Phase II Intergroup Study

Closed
Phase
Published
Abbreviated Title
Conservative Treatment of Adenocarcinoma of the Distal Rectum: Local Resection Plus Adjuvant 5-FU/Radiation Therapy, A Phase II Intergroup Study
Activated
07/01/1993
Closed
10/15/1995

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1999

Failure and salvage after sphincter sparing treatment for distal rectal adenocarcinoma-a CALGB coordinated intergroup study

G Steele;J Tepper;J Herndon;R Mayer Proc of the American Society of Clinical Oncology 18:235a(#903)

Sphincter-sparing treatment for distal rectal adenocarcinoma

GD Steele;JE Herndon;R Bleday;A Russell;A Benson;M Hussain;A Burgess;JE Tepper;RJ Mayer Annals of Surgical Oncology 6(5):433-441

Other Clinical Trials

SWOG Clinical Trial Number
S2303

Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS ≥ 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)
Research Committee(s)
Gastrointestinal Cancer
Activated
05/06/2024
Open
SWOG Clinical Trial Number
CTSU/A022101

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
SWOG Clinical Trial Number
S2107

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
Accrual
83%
Open
Phase